학술논문

Albumin induces excitatory synaptogenesis through astrocytic TGF-β/ALK5 signaling in a model of acquired epilepsy following blood–brain barrier dysfunction
Document Type
article
Source
Subject
Prevention
Neurosciences
Epilepsy
Neurodegenerative
Brain Disorders
2.1 Biological and endogenous factors
Aetiology
Neurological
Animals
Astrocytes
Blood-Brain Barrier
Disease Models
Animal
Hippocampus
Protein Serine-Threonine Kinases
Receptor
Transforming Growth Factor-beta Type I
Receptors
Transforming Growth Factor beta
Seizures
Serum Albumin
Signal Transduction
Synapses
Transforming Growth Factor beta
Albumin
TGF-beta
Synaptogenesis
Blood-brain barrier
Post-insult epilepsy
Post-traumatic epilepsy
ALK5
Blood–brain barrier
TGF-β
Clinical Sciences
Neurology & Neurosurgery
Language
Abstract
Post-injury epilepsy (PIE) is a common complication following brain insults, including ischemic, and traumatic brain injuries. At present, there are no means to identify the patients at risk to develop PIE or to prevent its development. Seizures can occur months or years after the insult, do not respond to anti-seizure medications in over third of the patients, and are often associated with significant neuropsychiatric morbidities. We have previously established the critical role of blood-brain barrier dysfunction in PIE, demonstrating that exposure of brain tissue to extravasated serum albumin induces activation of inflammatory transforming growth factor beta (TGF-β) signaling in astrocytes and eventually seizures. However, the link between the acute astrocytic inflammatory responses and reorganization of neural networks that underlie recurrent spontaneous seizures remains unknown. Here we demonstrate in vitro and in vivo that activation of the astrocytic ALK5/TGF-β-pathway induces excitatory, but not inhibitory, synaptogenesis that precedes the appearance of seizures. Moreover, we show that treatment with SJN2511, a specific ALK5/TGF-β inhibitor, prevents synaptogenesis and epilepsy. Our findings point to astrocyte-mediated synaptogenesis as a key epileptogenic process and highlight the manipulation of the TGF-β-pathway as a potential strategy for the prevention of PIE.